Long-term outcomes of ruxolitinib therapy in steroid-refractory graft-versus-host disease in children and adults. Moiseev IS, Morozova EV, Bykova TA, Paina OV, et al. Bone Marrow Transplant 2020 Feb 18. pii: 10.1038/s41409-020-0834.

Read + Share

Amedeo Smart

Independent Medical Education

Moiseev IS, Morozova EV, Bykova TA, Paina OV, et al. Long-term outcomes of ruxolitinib therapy in steroid-refractory graft-versus-host disease in children and adults. Bone Marrow Transplant 2020 Feb 18. pii: 10.1038/s41409-020-0834.
PMID: 32071418